Eric A Brock, Director, Chairman, Chief Executive Officer and President, on June 01, 2026, sold 2,378,245 shares in Ondas (ONDS) for $31,939,830. Following the Form 4 filing with the SEC, Brock has control over a total of 4,736,635 common shares of the company, with 3,583,010 shares held directly and 1,153,625 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1646188/000121390026064364/xslF345X05/ownership.xml
Robert C. Murphy, 10% Owner, Director, Chief Technology Officer, on May 29, 2026, sold 343,945 shares in Snap (SNAP) for $2,020,814. Following the Form 4 filing with the SEC, Murphy has control over a total of 53,773,372 Class A common shares of the company, with 43,809,791 shares held directly and 9,963,581 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1564408/000169932226000006/xslF345X05/ownership.xml
Peter A Feld, Director, on June 02, 2026, sold 1,900,000 shares in Qorvo (QRVO) for $192,286,963. Following the Form 4 filing with the SEC, Feld has control over a total of 5,614,022 common shares of the company, with 2,496 shares held directly and 5,611,526 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1604778/000119380526000739/xslF345X05/e665539_4-feld.xml
Kevin Tang, 10% Owner, Director, Chief Executive Officer, on May 29, 2026, executed a purchase for 814,606 shares in Aurinia Pharmaceuticals (AUPH) for $12,455,227. Following the Form 4 filing with the SEC, Tang has control over a total of 13,044,106 common shares of the company, with 13,044,106 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1600620/000117857926000004/xslF345X05/form4-06032026_010631.xml